HEATHER MURRAY: Open Payments
NPI 1538893250 · CANTONMENT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,193 in 57 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $57 · 2025 $1,193
Food & beverage: $1,098Education: $95
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $188 |
| Sumitomo Pharma America, Inc. | 5 | $123 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $95 |
| ABBVIE INC. | 4 | $92 |
| Astellas Pharma US Inc | 3 | $69 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $61 |
| Exact Sciences Corporation | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
Products named: GEMTESA, Wegovy, Ozempic, Veozah, XIFAXAN, AIRSUPRA, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across FL — which companies pay providers there.
